je.st
news
Celsion Co. (CLSN) Raised to "Buy" at Zacks Investment Research
2016-01-19 06:06:47| Biotech - Topix.net
The firm currently has a $1.50 price objective on the stock. Zacks Investment Research 's price objective would indicate a potential upside of 16.28% from the company's previous close.
Tags: buy
research
investment
raised
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||